Seres Therapeutics, Inc. (MCRB)
USD 0.86
(-2.31%)
USD 0.86
(-2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 126.32 Million | 7.12 Million | 144.92 Million | 33.21 Million | 34.5 Million | 28.26 Million |
| Cost of Revenue | 704 Thousand | 1 Million | 1.73 Million | 90.57 Million | 80.14 Million | 95.95 Million |
| Gross Profit | 125.62 Million | 6.12 Million | 143.19 Million | -57.35 Million | -45.63 Million | -67.68 Million |
| Operating Expenses | 234.3 Million | 253.61 Million | 209.42 Million | 121.34 Million | 104.88 Million | 128.55 Million |
| Selling, General and Administrative Expenses | 87.74 Million | 79.69 Million | 69.26 Million | 30.77 Million | 24.74 Million | 32.59 Million |
| Research and Development Expenses | 145.86 Million | 172.92 Million | 141.89 Million | 90.57 Million | 80.14 Million | 95.95 Million |
| Other Expenses | - | 1 Million | -1.73 Million | 981 Thousand | 1.06 Million | 170 Thousand |
| Cost and Expenses | 234.3 Million | 253.61 Million | 209.42 Million | 121.34 Million | 104.88 Million | 128.55 Million |
| Operating Income | -107.98 Million | -246.49 Million | -64.49 Million | -88.13 Million | -71.87 Million | -100.28 Million |
| Interest Expense | 13.17 Million | 6.02 Million | 2.91 Million | 2.92 Million | 502 Thousand | 1.17 Million |
| Income Tax Expense | - | 3.66 Million | -4.08 Million | -2.67 Million | -6.03 Million | 1.34 Million |
| Earnings before Tax | -113.72 Million | -250.15 Million | -65.57 Million | -89.12 Million | -70.27 Million | -98.94 Million |
| Net Income | -113.72 Million | -253.82 Million | -61.49 Million | -86.45 Million | -64.24 Million | -98.94 Million |
| Earnings Per Share Basic | -0.89 | -2.35 | -0.67 | -1.08 | -1.13 | -2.43 |
| Earnings Per Share Diluted | -0.89 | -2.35 | -0.67 | -1.08 | -1.13 | -2.43 |
| Weighted Average Shares Outstanding | 128 Million | 108.07 Million | 91.7 Million | 79.78 Million | 56.64 Million | 40.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 128 Million | 108.07 Million | 91.7 Million | 79.78 Million | 56.64 Million | 40.74 Million |
| Gross Margin | 0.99 | 0.86 | 0.99 | -1.73 | -1.32 | -2.39 |
| EBIT Margin | -0.68 | -34.25 | -0.43 | -2.60 | -1.98 | -3.55 |
| Profit Margin | -0.90 | -35.61 | -0.42 | -2.60 | -1.86 | -3.50 |
| EBITDA | -85.43 Million | -237.5 Million | -56.72 Million | -77.31 Million | -59.94 Million | -91.08 Million |
| Earnings Before Tax Margin | -0.85 | -34.58 | -0.45 | -2.65 | -2.08 | -3.55 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 64 Thousand | 126.32 Million | 310 Thousand | 126.47 Million |
| Cost of Revenue | 1.42 Million | 1.55 Million | 4.05 Million | 15.11 Million | 519 Thousand | 2.1 Million |
| Gross Profit | -1.42 Million | -1.55 Million | -3.98 Million | 111.21 Million | -209 Thousand | 124.36 Million |
| Operating Expenses | 32.51 Million | 35.6 Million | 40.02 Million | 218.49 Million | 47.72 Million | 76.94 Million |
| Selling, General and Administrative Expenses | 14.63 Million | 13.9 Million | 13.18 Million | - | 19.98 Million | 28.05 Million |
| Research and Development Expenses | 17.87 Million | 21.7 Million | 26.84 Million | - | 28.25 Million | 46.79 Million |
| Other Expenses | 692 Thousand | 2.46 Million | 336 Thousand | 15.11 Million | 999 Thousand | -1.51 Million |
| Cost and Expenses | 33.93 Million | 37.16 Million | 44.08 Million | 233.6 Million | 47.72 Million | 76.94 Million |
| Operating Income | -33.93 Million | -37.16 Million | -44.01 Million | -107.27 Million | -47.41 Million | 49.52 Million |
| Interest Expense | 3.44 Million | 4.66 Million | 4.02 Million | 13.17 Million | 4.01 Million | 3.18 Million |
| Income Tax Expense | -1.00 | 1.51 Million | -2.19 Million | 14.94 Million | 1.44 Million | 149 Thousand |
| Earnings before Tax | -32.86 Million | -40.13 Million | -41.24 Million | -113.72 Million | -47.85 Million | 46.55 Million |
| Net Income | -32.86 Million | -40.13 Million | -41.24 Million | -113.72 Million | -47.85 Million | 46.55 Million |
| Earnings Per Share Basic | -0.22 | -0.27 | -0.32 | - | -0.37 | 0.36 |
| Earnings Per Share Diluted | -0.22 | -0.27 | -0.32 | - | -0.37 | 0.36 |
| Weighted Average Shares Outstanding | 151.51 Million | 146.1 Million | 129.26 Million | 128 Million | 128.28 Million | 127.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 151.51 Million | 146.1 Million | 129.26 Million | 128 Million | 128.28 Million | 129.84 Million |
| Gross Margin | - | - | -62.33 | 0.88 | -0.67 | 0.98 |
| EBIT Margin | - | - | -624.42 | - | -141.43 | 0.39 |
| Profit Margin | - | - | -644.50 | -0.90 | -154.37 | 0.37 |
| EBITDA | -32.51 Million | -35.6 Million | -39.96 Million | - | -43.84 Million | 49.73 Million |
| Earnings Before Tax Margin | - | - | -687.75 | -0.85 | -152.95 | 0.39 |
0KSX
603777
PAGP
MBNKP
MBLV
0JUZ